Bank Of America Corp Exelixis, Inc. Put Options Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$20.17 - $23.93 $3.06 Million - $3.63 Million
-151,800 Reduced 98.38%
2,500 $59,000
Q4 2023

Feb 14, 2024
BUY
$19.25 - $24.13 $275,275 - $345,059
14,300 Added 10.21%
154,300 $3.7 Million
Q2 2023

Aug 14, 2023
BUY
$18.17 - $20.48 $1.91 Million - $2.15 Million
105,000 Added 300.0%
140,000 $2.68 Million
Q1 2023

May 12, 2023
BUY
$16.3 - $19.41 $570,500 - $679,350
35,000 New
35,000 $679,000
Q3 2021

Nov 15, 2021
BUY
$16.3 - $21.14 $326,000 - $422,800
20,000 New
20,000 $423,000

Others Institutions Holding EXEL

# of Institutions
468
Shares Held
240M
Call Options Held
2.04M
Put Options Held
1.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email